Topics such as supply chain, clinical trials and health data will be explored along with how blockchian can exist in harmony with GDPR.

One of the most fascinating and important applications for blockchain in healthcare is the decentralization of identity and health data to support vaccination verification. While many approaches and technologies have been introduced, this panel will highlight critical principles of Privacy by Design and using W3C Verifiable Credentials (VCs) with blockchain to securely share health data controlled by individuals.

The annual ConV2X is a leading international health tech symposium driving real world evidence, strategy, research, operations and trends to create a blueprint for a new digital health era. The 2021 symposium featured a scientific program of academic/research presentations in addition to business and industry talks. The research track focused on exploring and sharing developments in blockchain and emerging technologies in health and clinical medicine. Submissions were based on original research, conceptual frameworks, proposed applications, position papers, case studies, and real-world implementation. Selection was based on a peer-review process. Faculty, students, and industry researchers were encouraged to submit abstracts to present ideas before an informed and knowledgeable audience of industry leaders, policy makers, funders, and researchers.

This presentation was selected by the scientific review committee.

Submission Review Committee

• Dave Kochalko, CEO of ARTiFACTS
• Anjum Khurshid, UT Austin
• Carlos Caldas, UT Engineering
• Gil Alterovitz, Harvard Medical School
• Kayo Fujimoto, UT Health Houston
• Lei Zhang, University of Glasglow
• Sean Manion, CSciO of ConsenSys Health
• Vijayakuman Varadarajan, University of South Wales
• Vikram Dhillon, Wayne State University
• Yuichi Ikeda, Kyoto University

The annual ConV2X is a leading international health tech symposium driving real world evidence, strategy, research, operations and trends to create a blueprint for a new digital health era. The 2021 symposium featured a scientific program of academic/research presentations in addition to business and industry talks. The research track focused on exploring and sharing developments in blockchain and emerging technologies in health and clinical medicine. Submissions were based on original research, conceptual frameworks, proposed applications, position papers, case studies, and real-world implementation. Selection was based on a peer-review process. Faculty, students, and industry researchers were encouraged to submit abstracts to present ideas before an informed and knowledgeable audience of industry leaders, policy makers, funders, and researchers.

This presentation was selected by the scientific review committee.

Submission Review Committee

• Dave Kochalko, CEO of ARTiFACTS
• Anjum Khurshid, UT Austin
• Carlos Caldas, UT Engineering
• Gil Alterovitz, Harvard Medical School
• Kayo Fujimoto, UT Health Houston
• Lei Zhang, University of Glasglow
• Sean Manion, CSciO of ConsenSys Health
• Vijayakuman Varadarajan, University of South Wales
• Vikram Dhillon, Wayne State University
• Yuichi Ikeda, Kyoto University

Journal publisher and ConV2X curator shares vision and insights for scientific communications and scholarly publishing along with market predictions for the digital health and blockchain in healthcare emeging markets and research fields.

Biography

Tory Cenaj is the Founder and Publisher of Partners in Digital Health (PDH), a forward reaching publishing and communications company. PDH publishes Blockchain in Healthcare Today, the world’s first open access peer reviewed journal disseminating distributed ledger technology research and innovations in healthcare, and Telehealth and Medicine Today, the international  open access peer reviewed journal examining the value of telehealth and clinical automation. The portfolio includes the companion Converge2Xcelerate (ConV2X) annual symposium, pitch competition, and PDH Institute. Her leadership experience reflects all facets of healthcare publishing and communications heading a premier MM dollar multispecialty portfolio including digital and international licensing across five continenets. Her industry experience includes leading publication planning, P&L, medical education and clinical trials management. She currently serves as executive advisor to the IEEE SA in telehealth and DCT verticals in addition to her role as publisher.

The award was announced during the ConV2X 2021 conference, themed “Blueprint for a New Digital Health Era,” broadcast November 9-11, 2021. The winning article is titled: "The Last Mile: DSCSA Solution Through Blockchain Technology: Drug Tracking, Tracing, and Verification at the Last Mile of the Pharmaceutical Supply Chain with BRUINchain," by lead author William Chien (PharmD, MBA) and fellow authors from UCLA Health and LedgerDomain. The article is located at https://doi.org/10.30953/bhty.v3.134.

The groundbreaking article was part of the FDA’s Pilot Project Program for the Drug Supply Chain Security Act (DSCSA), and centered on a healthcare center pharmacy operating solely on commercial off-the-shelf (COTS) technology. It presented the highest number of BHTY 2020 reader engagements, with the most downloads and views.

The study demonstrated a 100% success rate across scanning, expiration detection, and counterfeit detection; and paperwork reduction from approximately 1 hour to less than a minute. Projecting out to 4.2 billion prescriptions being dispensed each year in the United States, the study found that distributed ledger technologies (such as blockchain) would not only save $183 million in annual labor costs, but also avert bad or fraudulent transactions, reduce the need for safety stock, and enhance the detection and removal of potentially dangerous drugs from the drug supply chain to protect U.S. consumers.

The annual ConV2X is a leading international health tech symposium driving real world evidence, strategy, research, operations and trends to create a blueprint for a new digital health era. The 2021 symposium  fetured a scientific program of academic/research presentations in addition to business and industry talks. The research track  focused on exploring and sharing developments in blockchain and emerging technologies in health and clinical medicine. Submissions were based on original research, conceptual frameworks, proposed applications, position papers, case studies, and real-world implementation. Selection was based on a peer-review process. Faculty, students, and industry researchers were encouraged to submit abstracts to present  ideas before an informed and knowledgeable audience of industry leaders, policy makers, funders, and researchers.

This presentation was selected by the scientific reveiw committee.

Submission Review Committee

• Dave Kochalko, CEO of ARTiFACTS
• Anjum Khurshid, UT Austin
• Carlos Caldas, UT Engineering
• Gil Alterovitz, Harvard Medical School
• Kayo Fujimoto, UT Health Houston
• Lei Zhang, University of Glasglow
• Sean Manion, CSciO of ConsenSys Health
• Vijayakuman Varadarajan, University of South Wales
• Vikram Dhillon, Wayne State University
• Yuichi Ikeda, Kyoto University

Swarm learning opens new opportunities for collaboration and innovation in clinical research where all members of the swarm have equal rights. Only algorithms and parameters are shared – with no central authority. Swarm creates many new opportunities in clinical research to develop new therapeutics, epidemiology, genetics research and more. This session will unlock swarm principals, challenges and opportunities in clinical R&D driving wider adoption of its application(s) in the health domain.

Key learnings will include:

• Understanding the differences between federated machine vs swarm learning
• The technical, policy and application barriers when it relates to transferring significant amounts of data
• The steps and frameworks needed to drive wider understanding and adoption of the technology in clinical R&D
• The pharma perspective: where does Swarm AI offer new solutions yet to be introduced to the drug development process

The annual ConV2X is a leading international health tech symposium driving real world evidence, strategy, research, operations and trends to create a blueprint for a new digital health era. The 2021 symposium featured a scientific program of academic/research presentations in addition to business and industry talks. The research track focused on exploring and sharing developments in blockchain and emerging technologies in health and clinical medicine. Submissions were based on original research, conceptual frameworks, proposed applications, position papers, case studies, and real-world implementation. Selection was based on a peer-review process. Faculty, students, and industry researchers were encouraged to submit abstracts to present ideas before an informed and knowledgeable audience of industry leaders, policy makers, funders, and researchers.

This presentation was selected by the scientific review committee.

Submission Review Committee

• Dave Kochalko, CEO of ARTiFACTS
• Anjum Khurshid, UT Austin
• Carlos Caldas, UT Engineering
• Gil Alterovitz, Harvard Medical School
• Kayo Fujimoto, UT Health Houston
• Lei Zhang, University of Glasglow
• Sean Manion, CSciO of ConsenSys Health
• Vijayakuman Varadarajan, University of South Wales
• Vikram Dhillon, Wayne State University
• Yuichi Ikeda, Kyoto University